Abstract
Background Hepatitis B viral infection is a public health problem and estimates show that about 30% of the world’s population is infected with the virus, with about 350 to 400 million of them remaining chronically infected. Northern Uganda has the highest prevalence of HBV in Uganda. In this study, we sought to establish factors influencing the prevalence of Hepatitis B viral infection among adults in Moyo district, North-Western Uganda.
Methods We used a descriptive cross-sectional study where quantitative data collection methods and analysis was employed. Self-reported HBV infection by respondents who had test result forms diagnosed with HBV within the last one year was reviewed by the researchers to confirm whether the respondent was negative or positive with Hepatitis B. 384 samples were determined using Cochran (1963:75) and a multi-stage sampling technique was used. Bivariate and multivariate analyses were done using SPSS (20.0).
Results Out of the 384 respondents interviewed, 29 (7.6%, 95%CI: 5.1-10.7) had HBV. Factors influencing the prevalence of HBV were; level of education (p=0.047*), ever having had STIs (aOR=18.090, 95%CI=5.699-57.426, p=0.000*), Health facilities have equipment for screening HEP B viral infection ANC (aOR=10.762, 95%CI=1.316-88.027, p=0.027*) were statically significant in influencing the prevalence of HBV, while the number of sexual partners ever had (p=0.984) was not statistically significant in influencing the prevalence of Hepatitis B viral infection.
Conclusion We found a high prevalence of HBV among adults in Moyo district in North-Western Uganda compared to the national prevalence. Key influences of HBV prevalence included education level, ever being infected with any other STIs (HIV, Syphilis, gonorrhoea), multiple sexual partners and presence of HBV screening equipment at the health facilities. Need for more emphasis on HBV childhood immunization, screening, vaccination of adults, other preventive measures and treatment of those already infected.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The authors received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by International Health Sciences University(Currently Clarke International University) Research Ethics Committee.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Not Applicable
Data Availability
All relevant data are within the manuscript and its supporting information files.
